Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...

In his new role as CFO at BioNTech, Ramón Zapata will ensure the Company’s financial direction continues to align with BioNTech’s strategy to become a multi-product company in the oncology field. In ...

Mainz, Germany, May 5, 2025(Nasdaq: BNTX, "BioNTech" or "the Company") announced today that the Supervisory Board has appointed Ramón Zapata-Gomez to the Management Board as Chief Financial Officer (" ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...